MAIA Biotechnology, Inc. Common Stock —— 季度现金流量表 (NYSE:MAIA)

Financials

总资产 10.16 M11.86 M11.05 M11.78 M9.7 M35.32 M 负债总额 6.52 M6.92 M7.17 M11.74 M7.33 M7.56 M 权益总额 3.63 M4.94 M3.88 M41.67 K2.38 M27.76 M 负债及股东权益总额 10.16 M11.86 M11.05 M11.78 M9.7 M35.32 M 总债务 —————— 净债务 ——————

MAIA Biotechnology, Inc. Common Stock

MAIA Biotechnology, Inc. is a public, immune-oncology company based in Chicago, IL focused on the development of telomere targeting agents for the treatment of telomerase-positive cancer cells.

新闻

MAIA Biotechnology股价因折价股票发行下跌29%

MAIA Biotechnology shares drop 29% on discounted stock offering

Stan Smith以每股1.224美元购入MAIA生物科技公司价值69,999美元股票

陆雅仪以99999美元购入MAIA Biotechnology (MAIA)股票

Chaouki Steven M以49999美元购买MAIA Biotechnology股票

迈亚生物科技CEO Vitoc Vlad购入价值1万美元股票

Maia生物科技CEO Vlad Vitoc购入价值$79,848的公司股票

Vitoc Vlad, CEO of Maia Biotechnology, buys $10k in shares

Vlad Vitoc, Maia Biotech CEO, buys $79,848 in Maia stock

Vitoc Vlad购买MAIA生物科技(MAIA)股票价值$79,848

Vitoc Vlad buys MAIA biotechnology (MAIA) shares worth $79,848

Maia Biotechnology董事Luput Cristian购入价值$41,845的股票